Expertise in
14
conditions

Dr. Waldemar A. Carlo

Neonatology
1700 6th Ave S Ste 9380, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Expertise in
14
conditions
1700 6th Ave S Ste 9380, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Waldemar Carlo is a Neonatologist in Birmingham, Alabama. Dr. Carlo is highly rated in 14 conditions, according to our data. His top areas of expertise are Premature Infant, Bronchopulmonary Dysplasia, Infant Respiratory Distress Syndrome, and Intraventricular Hemorrhage of the Newborn. Dr. Carlo is currently accepting new patients.

His clinical research consists of co-authoring 385 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neonatology
Licenses
Pediatrics in AL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1700 6th Ave S Ste 9380, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Cycled Phototherapy: a Safer Effective Method to Control the Serum Bilirubin of Extremely Premature Infants?
Cycled Phototherapy: a Safer Effective Method to Control the Serum Bilirubin of Extremely Premature Infants?
Enrollment Status: Recruiting
Publish Date: February 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease
National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease
Enrollment Status: Recruiting
Publish Date: May 02, 2024
Intervention Type: Other
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drugs: Morphine, Methadone
Study Phase: Phase 3
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Budesonide (Pulmicort Nebulizing Suspension), Surfactant (Poractant Alfa
Study Phase: Phase 3
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Other
Study Phase: Phase 3
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Enrollment Status: Active_not_recruiting
Publish Date: October 30, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Device
Study Phase: Phase 2/Phase 3
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Enrollment Status: Completed
Publish Date: July 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Enrollment Status: Active_not_recruiting
Publish Date: March 22, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Biological, Dietary supplement
Study Drug: Donor Breast Milk
Study Phase: Phase 3
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Enrollment Status: Completed
Publish Date: March 11, 2019
View 16 Less Clinical Trials

384 Total Publications

Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial.
Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial.
Journal: JAMA pediatrics
Published: February 24, 2025
Similar Doctors
Expertise in
16
conditions
Dr. Namasivayam Ambalavanan
Neonatology
Expertise in
16
conditions
Dr. Namasivayam Ambalavanan
Neonatology
Birmingham, AL 
 (0.8 mi)
205-996-2244
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Namasivayam Ambalavanan is a Neonatologist in Birmingham, Alabama. Dr. Ambalavanan is highly rated in 16 conditions, according to our data. Their top areas of expertise are Bronchopulmonary Dysplasia, Premature Infant, High Blood Pressure in Infants, Cerebral Hypoxia, and Gastrostomy. Dr. Ambalavanan is currently accepting new patients.

Expertise in
16
conditions
Dr. Alan T. Tita
Neonatology | Obstetrics and Gynecology
Expertise in
16
conditions
Dr. Alan T. Tita
Neonatology | Obstetrics and Gynecology
1500 6th Ave S, 
Birmingham, AL 
 (0.1 mi)
205-934-2170
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Alan Tita is a Neonatologist and an Obstetrics and Gynecologist in Birmingham, Alabama. Dr. Tita is highly rated in 16 conditions, according to our data. His top areas of expertise are Preeclampsia, Gestational Diabetes, Newborn Low Blood Sugar, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tita is currently accepting new patients.

Expertise in
8
conditions
Dr. Colm P. Travers
Neonatology | Pediatrics
Expertise in
8
conditions
Dr. Colm P. Travers
Neonatology | Pediatrics
1700 6th Ave S, 
Birmingham, AL 
 (0.2 mi)
205-934-3411
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Colm Travers is a Neonatologist and a Pediatrics provider in Birmingham, Alabama. Dr. Travers is highly rated in 8 conditions, according to our data. His top areas of expertise are Premature Infant, Infantile Apnea, Bronchopulmonary Dysplasia, and Cerebral Hypoxia. Dr. Travers is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carlo's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile